article thumbnail

Pharma companies team-up to reduce emissions  

Drug Discovery World

The post Pharma companies team-up to reduce emissions appeared first on Drug Discovery World (DDW). Through this, the Task Force will provide recommendations to governments that are committed to deliver climate resilient and low carbon health systems . References . 1: [link] .

article thumbnail

Large pharma companies support Women in STEM leadership pilot 

Drug Discovery World

The post Large pharma companies support Women in STEM leadership pilot appeared first on Drug Discovery World (DDW). The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI-driven drug company secures $372m Series D funding

Drug Discovery World

Formation Bio, a tech-driven and AI-native pharma company, has raised $372 million in a Series D financing. “We are thrilled to partner with the Formation Bio team on their journey to build an AI-enabled pharma company,” said Scott Kupor, Managing Partner at a16z.

article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1.

article thumbnail

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

Drug Channels

Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. Steve walks us through the expected Humira biosimilars launches and discusses potential responses from payers. To learn more, check out MMIT’s Strategic Launch Report & Evaluate Forecast solution. Read on for Steve’s insights.

article thumbnail

Pharma must embrace an AI future says new report

Drug Discovery World

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com.

article thumbnail

77% of researchers not using alternatives to animal testing

Drug Discovery World

More than 350 survey respondents participated in the survey by The Pistoia Alliance, including representatives from pharma companies, regulators, and CROs. The data revealed that regulatory concerns are a major barrier to non-animal model (NAM) adoption, experienced by 60% of respondents.